The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 05, 2003
Filed:
Apr. 20, 1999
Applicant:
Inventors:
Pablo Umaña, Manchester, GB;
Joël Jean-Mairet, Zürich, CH;
James E. Bailey, Zürich, CH;
Assignee:
Glycart Biotechnology AG, , CH;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P 2/100 ; C12N 1/563 ; C12N 1/585 ; C07H 2/104 ;
U.S. Cl.
CPC ...
C12P 2/100 ; C12N 1/563 ; C12N 1/585 ; C07H 2/104 ;
Abstract
The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
Published as:
WO9954342A1; AU3657899A; EP1071700A1; JP2002512014A; US6602684B1; US2004072290A1; EP1071700A4; US2005074843A1; US2005079605A1; US7517670B2; JP2009100748A; JP4334141B2; US2009304690A1; EP1071700B1; ATE458007T1; DE69942021D1; PT1071700E; EP2180007A2; ES2340112T3; DK1071700T3; EP2261229A2; US7906329B2; EP2180007A3; EP2261229A3; US2011142825A1; US2011294984A1; US2012122206A1; JP2012210209A; EP2180007B1; PT2180007E; ES2434961T3; US8623644B2; DK2180007T3; US8629248B2; JP2015051017A; US9068005B2; US9139654B2; US2016208009A1; JP2017108747A; US9718885B2; EP2180007B2; DK2180007T4; ES2434961T5; JP2018038431A; JP6329061B2;
Umaña, Pablo. (2003). Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity (U.S. Patent No. 6602684). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/6602684
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile